Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4393098
Author(s) Wagner, Sarah; Kurz, Mario; Klimkait, Thomas; Swiss, H. I. V. Cohort Study
Author(s) at UniBasel Klimkait, Thomas
Year 2015
Title Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping
Journal Antiviral Therapy
Volume 20
Number 6
Pages / Article-Number 661-5
Keywords Adolescent; Adult; Aged; Aged, 80 and over; *Algorithms; Anti-HIV Agents/*therapeutic use; Antiretroviral Therapy, Highly Active/methods/standards; Child; Child, Preschool; Drug Resistance, Viral/*genetics; Female; Genotype; Genotyping Techniques; HIV Infections/*drug therapy/virology; HIV Protease Inhibitors/*therapeutic use; HIV-1/drug effects/genetics; Humans; Male; Middle Aged; RNA, Viral/*antagonists & inhibitors/genetics; Retrospective Studies; Reverse Transcriptase Inhibitors/*therapeutic use; Time Factors; Viral Load/drug effects
Mesh terms Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Anti-HIV Agents, therapeutic use; Antiretroviral Therapy, Highly Active, standards; Child; Child, Preschool; Drug Resistance, Viral, genetics; Female; Genotype; Genotyping Techniques; HIV Infections, virology; HIV Protease Inhibitors, therapeutic use; HIV-1, genetics; Humans; Male; Middle Aged; RNA, Viral, genetics; Retrospective Studies; Reverse Transcriptase Inhibitors, therapeutic use; Time Factors; Viral Load, drug effects
Abstract BACKGROUND: Different genotypic HIV resistance algorithms are based on different rules. They may therefore result in different drug-resistance interpretations for the same patient sample. In particular, for early periods of new retroviral inhibitors or classes, sequence interpretation is expected to vary. One would, however, assume that those differences between systems wane with growing experience and that different algorithms yield similar results for well-established drugs. METHODS: To assess the concordance of the Agence Nationale de Recherche sur le SIDA (ANRS), Rega and Stanford-HIVdb algorithms and their evolution over time, we analysed 284 routine samples with the current versions of each algorithm in 2004 and 2013. For 446 recent clinical sequences the differences for actual drugs were analysed. Scoring as 'susceptible' by one algorithm and 'resistant' by a second one defined a discordance. RESULTS: The longitudinal analysis showed similar overall discordances for both time points as well as an evolution over time. The actual analysis demonstrated a higher overall discordance rate, mainly for certain drugs. Most deviations reflected differences between the ANRS and the other two algorithms. CONCLUSIONS: This study demonstrates discordances between three most commonly used interpretation tools even for long-available drugs. It thereby reveals a need for further adjustment and improvement of current interpretation tools and may point at a possibly crucial role of subtype-specific information.
Publisher INT MEDICAL PRESS LTD
ISSN/ISBN 1359-6535 ; 2040-2058
URL https://www.ncbi.nlm.nih.gov/pubmed/25710167
edoc-URL https://edoc.unibas.ch/62189/
Full Text on edoc No
Digital Object Identifier DOI 10.3851/IMP2947
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/25710167
ISI-Number WOS:000369398800011
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.379 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024